Anthony M. Bevilacqua, DOOrthopaedic SurgeonSports Medicine & Orthopaedic Center Jeffrey R. Carlson, MDOrthopaedic SurgeonOrthopaedic and Spine Center Snehal Damle, MDMedical Oncology/HematologyVirginia Oncology Associates Aarti Desai, MDInfectious DiseaseChesapeake Regional Healthcare Daniel J. Dickinson, MD, MPH Internal … [Read more...] about 2021 Advisory Board
The Value of Going Solar
By Alison Johnson Patients in the waiting room at Hampton Family Practice have a unique program to watch – a real-time display of the energy watts produced by the office’s 350-plus rooftop solar panels. Figures on a television screen dip if a cloud blocks the sun and rise once it drifts away. The panels, added in the spring of 2020, have quickly turned into a valuable … [Read more...] about The Value of Going Solar
The Proven Effectiveness of Cervical Disc Replacement
By Mark B. Kerner, MD Over the past two years, multiple studies have clearly demonstrated the benefits of cervical disc replacement for one- or two-level pathology as compared to cervical fusion, the longtime gold standard of care. Cervical disc arthroplasty, an outpatient procedure performed through an inch-long incision in the neck, has improved outcomes by combining … [Read more...] about The Proven Effectiveness of Cervical Disc Replacement
Moving Closer to the Medical Treatment of Hearing Loss
By Peter G. Volsky, MD Over the past two years, clinical trials of prospective medical treatments for acquired sensorineural hearing loss have multiplied. This promising area of research is focused on experimental molecular-based pharmaceuticals that target cells in the inner ear to regenerate hearing, generally by stimulating the growth of new nerve endings or … [Read more...] about Moving Closer to the Medical Treatment of Hearing Loss
New Treatment Approach for Triple-Negative Breast Cancer
By Sonia E. Hepburn, MD Until recently, breast cancer has remained largely in the background as immunotherapy has gained ground in treating many other types of cancer. However, evidence now supports a combination of immunotherapy and chemotherapy agents as a first-line treatment for a subset of patients with the most aggressive form of the disease, metastatic triple-negative … [Read more...] about New Treatment Approach for Triple-Negative Breast Cancer
